Kronos Bio, Inc.

NASDAQ:KRON

0.98 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -14.109-16.2-29.958-25.32-31.374-29.741-26.238-31.782-32.256-32.903-36.263-62.334-33.603-29.055-26.086-33.157-39.713-8.579-6.995-5.465-4.013-3.32-3.32
Depreciation & Amortization -0.3850.421.2720.4780.510.5790.5690.5740.5710.5640.5570.5460.5230.4640.4440.30.1960.1830.160.1410.090.0630.063
Deferred Income Tax 000-9.332-1.3681.434000000.8221.1011.1310.9430.2210.04100-0.004000
Stock Based Compensation 2.0312.2023.3275.1736.2966.9066.6077.6897.4618.2077.7887.4047.1376.4325.2382.0191.2530.2930.1880.0530.0230.0190.019
Change In Working Capital 11.887-3.294-8.593-5.2942.598-4.99913.5710.9711.5630.6043.04-5.8514.1690.076-0.0140.5674.2672.062-0.4360.2220.351-0.161-0.161
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables 0.289-1.2361.347-3.2031.605-3.5551.0053.616-1.878-1.3833.67-2.5450.838-0.289-1.1991.6780.8350.538-0.2440.4580.23400
Other Working Capital 11.598-2.058-9.94-2.0910.993-1.44412.566-2.6453.4411.987-0.63-3.3063.3310.3651.185-1.1113.4321.524-0.192-0.2360.117-0.161-0.161
Other Non Cash Items -11.7950.54214.5779.2710.7520.796-0.4560.020.2671.0081.3940.8910.5330.6880.47714.4223.671.1110.0170.1110.0630.0720.072
Operating Cash Flow -12.371-16.33-23.899-25.024-22.586-25.025-5.947-22.528-22.394-22.52-23.484-58.522-20.14-20.264-18.998-15.63-10.286-4.93-7.066-4.942-3.486-3.327-3.327
Investing Activities:
Investments In Property Plant And Equipment 0.0070-0.007-0.031-0.214-0.308-0.126-0.052-0.073-0.086-0.366-0.478-0.926-1.351-1.505-3.682-4.165-1.095-0.626-0.637-1.459-0.426-0.426
Acquisitions Net 000-31.591-36.003-5.6826.229-31.788-3.1840.6430000000000000
Purchases Of Investments -23.622-6.4-48.754-42.141-30.496-37.725-102.595-59.943-91.064-121.573-94.544-14.119-22.419-15.136-126.06-188.123-33.047-5.849-2.309-64.633000
Sales Maturities Of Investments 40.74446.57654.53173.73266.49943.40796.36691.73194.24480.9368.57453.34673.43979.51739.41633.0516.43120.9358.2450000
Other Investing Activites 005.77731.59136.0035.682-6.22931.7883.18-40.643-25.9739.22751.0264.381-86.644-155.073-16.61615.0865.936-64.633000
Investing Cash Flow 17.12940.1765.7731.5635.7895.374-6.35531.7363.107-40.729-26.33638.74950.09463.03-88.149-158.755-20.78113.9915.31-65.27-1.459-0.426-0.426
Financing Activities:
Debt Repayment 00000000000000-0.005-0.008151.267-0.008-0.008-0.008-0.00700
Common Stock Issued 0000.19100.3760-0.7160.6280.410.5291.051.3811.4440.59263.3140.2780.1130.020.0590.0100
Common Stock Repurchased 0.162000.538000-0.7160000.52100000000000
Dividends Paid 00000000000000000000000
Other Financing Activities -0.0010.16400.19100.3760-0.7160.6280.410.5291.051.3811.44402.893-2.24800-0.007100.36827.39127.391
Financing Cash Flow -0.0010.16400.19100.3760-0.7160.6280.410.5291.051.3811.4440.585266.199149.2970.1050.0120.04450.18227.39127.391
Other Information:
Effect Of Forex Changes On Cash 000-00000000000000000000
Net Change In Cash 4.75724.01-18.1296.72713.203-19.275-12.3028.492-18.659-62.839-49.291-18.72331.33544.21-106.56291.814118.239.166-1.744-70.16845.23723.63823.638
Cash At End Of Period 76.9970.20746.19764.32659.62546.42265.69777.99969.50788.166151.005200.296219.019187.684143.474250.036158.22239.99230.82632.57102.73857.50123.638